Pharmaceutical company Wellgistics Health Inc. announced a $50 million credit line for the integration of XRP into its financial operations. The goal of this initiative is to enhance transaction speed and transparency in its network.
As a result, XRP will be used as a treasury reserve asset and a real-time payment medium, making Wellgistics Health Inc. one of the first publicly traded healthcare companies with such integration.
Processing transactions in the XRP ledger in 3–5 seconds at a cost of less than $0.0002 is a significant advantage over bank payments.
CEO Brian Norton, who has already signed over 150 direct contracts with manufacturers and has a network of more than 6,000 pharmacies nationwide, emphasized that this move contributes to the modernization of payments in the healthcare system.
It is quite likely that institutional adoption of XRP was spurred by the launch of XRP futures by CME Group and the recognition of the token by payment giant Mastercard as an intermediary currency for cross-border payments.
